Biblio Discovery — Demo Discovery Service

13 results for "Simone Theilade"

Showing 1–13 · 1.01 seconds · RSS

  1. Journal Article

    ARTERIAL INFLAMMATION, BLOOD PRESSURE AND CENTRAL HEMODYNAMICS – THE ABC OF DIABETIC ANGIOPATHY

    Simone Theilade

    Artery Research, Vol. 16 · 2016 · English · DOAJ Scopus

    Aim: In diabetes patients, we explored relationships between markers of diabetic angiopathy, diabetic complications and adverse outcome. Methods: Patients were recruited from 3 observational studies from Steno Diabetes Center, Denmark and one randomized, double-blind, international, multicentre…

  2. Journal Article

    Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

    Christian S. Hansen; Tommi Suvitaival; Simone Theilade et al.

    Frontiers in Endocrinology, Vol. 13 · 2022 · English · DOAJ Scopus

    IntroductionDiabetic cardiovascular autonomic neuropathy (CAN) is associated with increased mortality and morbidity. To explore metabolic mechanisms associated with CAN we investigated associations between serum metabolites and CAN in persons with type 1 diabetes (T1D).Materials and…

  3. Journal Article

    3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES

    Tine Willum Hansen; Marie Frimodt-Møller; Simone Theilade et al.

    Artery Research, Vol. 24 · 2018 · English · DOAJ Scopus

    Purpose: The prognostic significance of carotid-femoral pulse wave velocity (cfPWV) remains to be determined in patients with type 1 diabetes (T1D). We investigated the predictive value of cfPWV for various endpoints in T1D. Methods: At baseline, cfPWV was measured using the SphygmoCor device in…

  4. Journal Article

    Mapping shared genetic determinants of eGFR and albuminuria with a focus on type 2 diabetes: a large-scale European study

    Thomas Kümler; Peter Rossing; Simone Theilade et al.

    BMJ Open Diabetes Research & Care, Vol. 14 No. 3 · 2026 · English · DOAJ Scopus

    Background and hypothesis Chronic kidney disease (CKD) is a global health and economic burden, particularly among individuals with type 2 diabetes (T2D). According to Kidney Disease: Improving Global Outcomes guidelines, key CKD indicators include urine albumin-creatinine ratio (UACR) and estimated…

  5. Journal Article Full text

    Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

    Linda Ahonen; Sirkku Jäntti; Tommi Suvitaival et al.

    Metabolites, Vol. 9 No. 9 · 2019 · English · DOAJ Scopus

    Several small molecule biomarkers have been reported in the literature for prediction and diagnosis of (pre)diabetes, its co-morbidities, and complications. Here, we report the development and validation of a novel, quantitative method for the determination of a selected panel of 34 metabolite…

  6. Journal Article

    P153 MARKER OF TYPE VI COLLAGEN FORMATION (PRO-C6) IS ASSOCIATED WITH HIGHER ARTERIAL STIFFNESS IN TYPE 1 DIABETES

    Tine Willum Hansen; Daniel G.K. Rasmussen; Simone Theilade et al.

    Artery Research, Vol. 20 · 2017 · English · DOAJ Scopus

    Aim: Arterial stiffening reflects fragmentation and loss of elastin fibers and accumulation of stiffer collagen fibers in the media of large arteries. We evaluated associations between carotid-femoral pulse wave velocity (cfPWV) and a marker of collagen type VI formation (Pro-C6) and a marker of…

  7. Journal Article

    Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus

    Ninna Hahn Tougaard; Simone Theilade; Signe Abitz Winther et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 9 No. 19 · 2020 · English · DOAJ Scopus

    Background The value of carotid‐femoral pulse wave velocity (cfPWV) as risk factor for development of complications in type 1 diabetes mellitus remains to be determined. We investigated associations between cfPWV and renal outcomes, cardiovascular events, and all‐cause mortality in people with type…

  8. Journal Article

    Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

    Simone Theilade; Christian Stevns Hansen; Tine W Hansen et al.

    BMJ Open Diabetes Research & Care, Vol. 9 No. 1 · 2021 · English · DOAJ Scopus

    Introduction We investigated the association between cardiovascular autonomic neuropathy (CAN) and decline in kidney function in type 1 diabetes.Research design and methods We included 329 persons with type 1 diabetes. CAN was assessed by cardiovascular reflex tests (CARTs): heart rate response to…

  9. Journal Article

    Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?

    Christian S. Hansen; Daniel G. K. Rasmussen; Tine W. Hansen et al.

    Cardiovascular Diabetology, Vol. 22 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Diabetic cardiovascular autonomic neuropathy (CAN) and distal symmetrical polyneuropathy (DSPN) are severe diabetic complications. Collagen type VI (COL6) and III (COL3) have been associated with nerve function. We investigated if markers of COL6 formation (PRO-C6) and COL3…

  10. Journal Article

    Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

    Stijn A. Peeters; Lian Engelen; Jacqueline Buijs et al.

    Cardiovascular Diabetology, Vol. 16 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background Altered regulation of extracellular matrix (ECM) composition by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) may contribute to arterial stiffening. We investigated associations between circulating MMP-1, -2, -3, -9, -10 and TIMP-1, and…

  11. Journal Article

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Luis F. Ferreira-Divino; Tommi Suvitaival; Viktor Rotbain Curovic et al.

    Cardiovascular Diabetology, Vol. 21 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Cardiovascular disease remains the leading cause of mortality in individuals with diabetes and improved understanding of its pathophysiology is needed. We investigated the association of a large panel of metabolites and molecular lipid species with future cardiovascular events…

  12. Journal Article

    Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes

    Nete Tofte; Tommi Suvitaival; Kajetan Trost et al.

    Frontiers in Endocrinology, Vol. 10 · 2019 · English · DOAJ Scopus

    Background: Improved understanding of the pathophysiology causing diabetic kidney disease (DKD) is imperative. The aim of this study was to uncover associations between serum metabolites and renal outcomes.Methods: Non-targeted serum metabolomics analyses were performed in samples from 637 persons…

  13. Journal Article

    Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes

    Peter Rossing; Simone Theilade; Christian Stevns Hansen et al.

    BMJ Open Diabetes Research & Care, Vol. 12 No. 2 · 2024 · English · DOAJ Scopus

    Introduction Diabetic retinopathy (DR), diabetic kidney disease (DKD) and distal symmetric polyneuropathy (DSPN) share common pathophysiology and pose an additive risk of early mortality.Research design and methods In adults with type 1 diabetes, 49 metabolites previously associated with either DR…